Navigation Links
Vistaril

ProductsVistaril
Company ARUP Laboratories
Item Vistaril
Features 
Description ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, major commercial laboratories, military and government facilities, and major clinics.
Info ARUP Laboratories
Customer Service: (800) 522-2787
Web site: http://www.aruplab.com

Related medicine products :

1. Vistaril, Urine
TAG: Vistaril
The new Nellcor N-45 Handheld Pulse Oximeter is compatible with our complete line of OxiMax Pulse Oximetry Sensors, so clinicians have the convenience of Nellcors most advanced sensor technology in a
...or's most popular handheld oximeter has been conve... and is now compatible with the entire line of inn...ehead Sensor and SoftCare Nonadhesive Sensors. The...also incorporates Nellcor's latest advanced signal...
...ellcor N395 Pulse Oximeter with Oxismart XL Advanc...ion conditions, cutting through nonspecific noise ...rate values. , ,The N395 monitor is also equi...ugh in clinician-programmable alarm sensitivity fo...
...e cornerstone of the revolutionary OxiMax® Pul...r combines Nellcor's best-in-class pulse oximetry ... motion-tolerant OxiMax N-595 Pulse Oximeter is eq...ing technology, which enables it to withstand the ...
Medicine Products:
(Date:9/8/2008)...aser scalpels, arthroscopic,surgery, genomic resea...rinary medicine is quickly expanding into new high...e benefit; it,s improving medicine for,people, too... care for their pets to,treat diseases like diabet... according to the American Veterinary Medical Asso...
(Date:9/8/2008)...zine examines Iraq and Afghanistan veterans, strug..., Washington, DC (PRWEB) S...by veterans of the Iraq and Afghanistan wars about... addiction disorders are featured in the current i...ublication of the National Council for Community B...
(Date:9/7/2008)...f older patients successfully treated for colorect...le to detect any recurrence of cancer. The study, ... , a peer-reviewed journal of the American Cancer ...monitoring of colorectal cancer survivors could af...y curative surgery for colorectal cancer have an i...
(Date:9/7/2008)... appear to lower a man,s PSA level, the blood biom...her a man is at risk of prostate cancer. , But t.... 8 in the journal Cancer , caution that men shou... prostate cancer just yet. , "We showed that me...rin and other non-steroidal anti-inflammatory drug...
Breaking Medicine News(10 mins):Health News:High-Tech Vet Medicine Saving Lives of Pets and People 2Health News:Helping Veterans in Our Communities 2Health News:Helping Veterans in Our Communities 3Health News:Many colorectal cancer survivors do not receive recommended follow-up care 2Health News:Common painkillers lower levels of prostate cancer biomarker 2
...unique public-private partnership in healthcare, t...ll ensure medical care for the poor that will be p... The Sarva Swasthya Mission Trust is the brainchi...as roped in major investors to provide funds. He h...
...ia become a "near-epidemic" in the Dooars region o...re than 20,000 persons in the past two and a half ...y.// Nirmal Das, an MLA from Alipurduar constitue...at 48 deaths had been reported from Alipurduar sub...
...n biotech major Biocon Ltd has roped in Bayer Heal...ugen in the Chinese market, the company //said in ...h firm plans to launch Insugen in China by 2007-08...stration trials and seeking the regulatory approva...
...aldomero Olivera said that the ruthless fish-eatin... back pain.// He is planning to present his findi...snails, with their striking patterns and elegant s...tching shells on display and for sale at the annua...
Other Medicine News:Health News:Bayer to Market Biocon Insulin in China 2
(Date:9/4/2008)...ublished in ,The Lancet, and Presented at ESC Cong...lts from a new international,study, the GISSI Hear... of,omega-3 acid ethyl esters reduced all cause mo... reasons in patients with chronic heart,failure. T...version of ,The,Lancet, and were presented at the ...
(Date:9/4/2008)...itzerland, September 4 /- Axentis Pha... assess the safety and tolerability,of a new thera...monary,infection in cystic fibrosis patients. The ...agent to be delivered directly to the site of,infe... effects of two,different doses of the new drug. I...
(Date:9/4/2008)...cements Remain on Schedule with Two Abstracts Acce... Release in November 2008, BRIDGEWATER, N.J., Sep...., a specialty pharmaceutical company focused on t...se, today announced the appointment of,Peter L. Ga..., Peter Garrambone,s career includes more than 50...
(Date:9/3/2008)... College of Rheumatology Research and Education Fo...ficant Advances in Detecting, ...- For the first time during its,unpre...arthritis, the,American College of Rheumatology Re...nformation acquired from research funded by the Wi...
Breaking Medicine Technology:New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 2New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 3New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 4Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 2Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 3Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 4Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials 2New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis 2New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis 3ImaRx Therapeutics Transitions Business Strategy 1285 1ImaRx Therapeutics Transitions Business Strategy 1285 2ImaRx Therapeutics Transitions Business Strategy 1285 3ImaRx Therapeutics Transitions Business Strategy 1285 4ImaRx Therapeutics Transitions Business Strategy 1285 5EMH Regional Medical Center Selects TransUnions Healthcare Revenue Cycle Platform to Help Reduce Its Bad Debt 10446 1EMH Regional Medical Center Selects TransUnions Healthcare Revenue Cycle Platform to Help Reduce Its Bad Debt 10446 2EMH Regional Medical Center Selects TransUnions Healthcare Revenue Cycle Platform to Help Reduce Its Bad Debt 10446 3Topspin Medical Announces First Commercial Installation of the Cathamaran 28TM 29 Intravascular MRI System 2840 1Topspin Medical Announces First Commercial Installation of the Cathamaran 28TM 29 Intravascular MRI System 2840 2Topspin Medical Announces First Commercial Installation of the Cathamaran 28TM 29 Intravascular MRI System 2840 3Asthma Foundation Announces 2008 Asthma Capitals Knoxville on Top Again 10440 1Asthma Foundation Announces 2008 Asthma Capitals Knoxville on Top Again 10440 2Asthma Foundation Announces 2008 Asthma Capitals Knoxville on Top Again 10440 3
...May 31, 2007 - Hemispherx Biopharma, Inc.,(AMEX: H...inical,development and manufacture of new drug ent...y a new scientific report featuring,its antiviral ...ting highly pathogenic avian influenza (HPAI), als...xperimental oral formulation,of the Company,s Alfe...
...ESS WIRE)--May 30, 2007 - People with a,class of r...age,coma and death can be successfully treated wi...sity School of Medicine and Lucile,Packard Childre...ecedented 25-year study that,prompt diagnosis coup... significantly improves the survival rates of peop...
Other Medicine Technology:Hemispherx Presents Potential Avian Influenza Treatment,Breakthrough at Paris Conference 2Hemispherx Presents Potential Avian Influenza Treatment,Breakthrough at Paris Conference 3Hemispherx Presents Potential Avian Influenza Treatment,Breakthrough at Paris Conference 4Once-Fatal Metabolic Disorders Treatable, Says Stanford/Packard,Researcher 2Once-Fatal Metabolic Disorders Treatable, Says Stanford/Packard,Researcher 3Once-Fatal Metabolic Disorders Treatable, Says Stanford/Packard,Researcher 4